17
Participants
Start Date
May 17, 2022
Primary Completion Date
September 1, 2023
Study Completion Date
September 1, 2023
Autologous platelet-rich plasma
PRP created using a commercially available system will be used for treatment. PEFA-PRP will be created by subjecting PRP to a pulsed electrical field in a specially designed instrument developed by sponsor. Two 9 cm2 contralateral regions of interest (ROI) on the scalp will be treated with approximately 6mL of either PRP or PEFA-PRP by subcutaneous injection.
Lahey Hospital and Medical Center, Burlington
Santiste Medical Inc.
INDUSTRY